Kurt Hu

Dr. Kurt Hu

orcid

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2021 in Respiratory Medicine
Verified
Journal Article
Closed access
ACAmit Chopra
Amit Chopra
AAAli Hani Al-Tarbsheh
Ali Hani Al-Tarbsheh
NSNidhi J. Shah
Nidhi J. Shah
HYHamid Yaqoob
Hamid Yaqoob
KHKurt Hu
Kurt Hu
Marc JudsonMarc Judson
Marc Judson

Verified
Journal Article
Open access
PDF file
LSLalita Subedi
Lalita Subedi
STStephanie Tchen
Stephanie Tchen
Bhakta Prasad GaireBhakta Prasad Gaire
Bhakta Prasad Gaire
BHBingren Hu
Bingren Hu
KHKurt Hu
Kurt Hu
The novel coronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2/COVID-19), is a worldwide pandemic, as declared by the World Health Organization (WHO). It is a respiratory virus that infects people of all ages. Although it may present with mild to no symptoms in most patients, those who are older, immunocompromised, or with multiple comorbidities may present with severe and life-threatening infections. Throughout history, nutraceuticals, such as a variety of phytochemicals from medicinal plants and dietary supplements, have been used as adjunct therapies for many disease conditions, including viral infections. Appropriate use of these adjunct therapies with antiviral proprieties may be beneficial in the treatment and/or prophylaxis of COVID-19. In this review, we provide a comprehensive summary of nutraceuticals, such as vitamins C, D, E, zinc, melatonin, and other phytochemicals and function foods. These nutraceuticals may have potential therapeutic efficacies in fighting the threat of the SARS-CoV-2/COVID-19 pandemic.

1 May 2020 in Journal of Thoracic Disease
Verified
Journal Article
Open access
PDF file
KHKurt Hu
Kurt Hu
ACAmit Chopra
Amit Chopra
JHJohn Terrill Huggins
John Terrill Huggins
RNRahul Nanchal
Rahul Nanchal
Pleural manometry (PM) is a novel tool that allows direct measurement of the pressure in the pleural space in the presence of either a pleural effusion or a pneumothorax. Originally it was used to guide therapy for tuberculosis (TB) before the development of anti-TB medications. It was relegated to highly specialized centers for thoracoscopies until Light used it to investigate pleural effusions in the 1980s. However, there remains lack of robust data to support the routine use of PM. Recently additional published studies have generated renewed interest supporting the use of PM in specialized cases of complex pleural disorders. In this paper we summarize the current different techniques, applications, and pitfalls for the use of PM.

1 August 2021 in Journal of Thoracic Disease
Verified
Journal Article
Open access
PDF file
KHKurt Hu
Kurt Hu
ACAmit Chopra
Amit Chopra
JKJonathan Kurman
Jonathan Kurman
JHJ. Terrill Huggins
J. Terrill Huggins
Management of complex pleural disease in the critically Ill patient Kurt Hu, Amit Chopra, Jonathan Kurman, J. Terrill Huggins

5 February 2018 in Journal of General Internal Medicine
Verified
Journal Article
Open access
PDF file
DBDerek N. Bremmer
Derek N. Bremmer
BDBriana E. DiSilvio
Briana E. DiSilvio
CHCrystal Hammer
Crystal Hammer
MBMoeezullah Beg
Moeezullah Beg
SVSwati Vishwanathan
Swati Vishwanathan
TWThomas L. Walsh
Thomas L. Walsh
Antibiotics are often prescribed for hospitalized patients with chronic obstructive pulmonary disease (COPD) exacerbations. The use of procalcitonin (PCT) in the management of pneumonia has safely reduced antibiotic durations, but limited data on the impact of PCT guidance on the management of COPD exacerbations remain.